Latest from the Blog

1. October 9, 2020

   NBTS Brain Tumor Clinical Trials Report: Q3 2020

   

   It can be hard for patients and care partners to keep track of new clinical trial opportunities opening across the country, especially during the current public health crisis created by the coronavirus (COVID-19). However, there are many brain tumor clinical trials still actively enrolling patients, and this report provides a summary of the studies that […]

   Read more | 

   Tags: astrocytoma, biopharma, brain cancer, brain tumor, childhood cancer, Clinical trials, DIPG, Ependymoma, GBM, glioblastoma, glioma, high-grade glioma, immunotherapy, low-grade glioma, Medulloblastoma, Oligodendroglioma, pediatric, pediatric brain tumor, pediatric cancer, precision medicine, Treatment
2. August 25, 2020

   Build Me Up: Glioblastoma Caregiver Gets National Platform (Q&A)

   

   Corie Yutkin is a member of the NBTS Board of Directors, a long-time advocate, and a dedicated supporter of our vision to conquer and cure brain tumors – once and for all. Corie became involved with NBTS following her husband, Michael’s, glioblastoma diagnosis. Corie and Michael began participating in the Orange County Brain Tumor Walk […]

   Read more | 

   Tags: brain cancer, brain tumor, Community, GBM, glioblastoma
3. July 23, 2020

   Sights & Sounds: Glioblastoma Awareness Day (#GBMDay) 2020

   

   Perhaps Dr. Ned Sharpless, Director of the National Cancer Institute, summed up Glioblastoma (GBM) Awareness Day 2020 best when he said during NBTS’s Defeating GBM: A Virtual Town Hall event, “Events like this are really important to re-energize the community so we can join together and make progress in a disease that where progress has been […]

   Read more | 

   Tags: #GBMDay, advocacy, astrocytoma, brain cancer, brain tumor, brain tumor community, Community, Defeat GBM, FDA, GBM, glioblastoma, glioblastoma multiforme, NCI, Patient life, Treatment